Dr. Lal Pathlabs Ltd.

2355.70 +43.20 ▲1.9%

29 February 2024, 04:01:00 PM
Volume: 2,625

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Hospital & Healthcare Services Industry Icon Hospital & Healthcare Services Compare with Industry peers
Website http://www.lalpathlabs.com
Market Cap 19,619.80 Cr.
Enterprise Value(EV) 19,003.48 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 39.52 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) 59.47 Trailing Twelve Months Ending 2023-12
Industry PE 66.95 Trailing Twelve Months Ending 2023-12
Book Value / Share 222.14 Trailing Twelve Months Ending 2023-12
Price to Book Value 10.58 Calculated using Price: 2,350.30
Dividend Yield 0.51 Period Ending 2023-03
No. of Shares Subscribed 8.35 Cr. 83,477,852 Shares
FaceValue 10
About Dr. Lal Pathlabs Ltd.
The company is a provider of diagnostic and related healthcare tests and services in India. Through its integrated, nationwide network, the company offers patients and healthcare providers a broad range of diagnostic and related healthcare tests and services for use in core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions. Its customers include individual patients, hospitals and other healthcare providers and corporate customers.

Dr. Lal Pathlabs Ltd. Delivery

Delivered Qty
Traded Qty

Dr. Lal Pathlabs Ltd. Performance

1 Day
+1.87%
1 Week
-2.95%
1 Month
-1.88%
3 Month
-10.98%
6 Month
+7.71%
1 Year
+18.49%
2 Year
-6.48%
5 Year
+134.44%
10 Year

Dr. Lal Pathlabs Ltd. Fundamental Ratios

9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 37.14 32.45 28.45 25.32 23.76 23.74 26.89 26.45 15.8
Return on Capital Employed (%) 48.87 47.43 43.07 37.9 34.78 32.94 36.03 32.67 20.34
Return on Assets (%) 24.67 25.06 24.13 21.81 20.38 18.81 19.87 17.77 10.36

Dr. Lal Pathlabs Ltd. Balance Sheet

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 341 507 596 788 946 1,033 1,245 1,502 1,666 1,772
Non Curr. Liab. -5 12 -6 -9 -20 70 83 273 176 122
Curr. Liab. 112 91 85 116 138 227 274 500 470 471
Minority Int. 2 3 2 4 5 21 31 35 33 34
Equity & Liab. 450 613 676 899 1,069 1,351 1,633 2,310 2,345 2,399
Non Curr. Assets 168 189 210 276 255 459 488 1,435 1,372 1,320
Curr. Assets 282 424 467 623 814 893 1,145 875 973 1,079
Misc. Exp. not W/O
Total Assets 450 613 676 899 1,069 1,351 1,633 2,310 2,345 2,399

Dr. Lal Pathlabs Ltd. Profit and Loss

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 660 791 912 1,057 1,203 1,330 1,581 2,087 2,017 2,172
Other Income 13 22 28 31 46 55 51 53 42 65
Total Income 673 813 940 1,088 1,249 1,385 1,633 2,140 2,059 2,237
Total Expenditure -504 -584 -675 -793 -910 -987 -1,145 -1,527 -1,527 -1,592
PBIDT 168 229 265 295 340 399 488 613 532 645
Interest 0 -1 -1 -1 -1 -15 -16 -30 -38 -32
Depreciation -28 -28 -28 -33 -38 -73 -77 -108 -150 -145
Taxation -43 -67 -81 -90 -100 -83 -98 -125 -103 -135
Exceptional Items
PAT 96 133 156 172 200 228 296 350 241 333
Minority Interest -1 -1 -1 -1 -1 -2 -5 -5 -2 -4
Share Associate
Other Related Items
Consolidated Net Profit 96 132 155 171 199 226 292 345 239 330
Adjusted EPS 17 16 19 20 24 27 35 41 29 40

Dr. Lal Pathlabs Ltd. Cash Flow

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 98 122 159 171 197 219 284 398 447 456
Cash Fr. Inv. -90 -113 -163 -137 -172 -100 -26 -212 -449 -287
Cash Fr. Finan. -10 -1 0 -32 13 -55 -190 -139 136 -283
Net Change -2 8 -5 2 37 64 67 48 134 -114
Cash & Cash Eqvt 16 23 19 29 66 129 197 244 378 264

Dr. Lal Pathlabs Ltd. Shareholding Pattern

9 Qtrs 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%)
Promoter 55.23 55.23 55.05 55.05 55.05 55.03 55.01 54.61 54.60
Public 44.77 44.77 44.95 44.96 44.95 44.97 44.99 45.39 45.40
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Dr. Lal Pathlabs Ltd. Announcements

Fri, 23 Feb 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Analyst/ Institutional Investor Meeting
Wed, 14 Feb 2024
Announcement under Regulation 30 (LODR)-Credit Rating
CARE Ratings Limited vide its letter dated February 14 2024 re-affirmed the Credit Rating for the bank facilities of the Company.
Wed, 07 Feb 2024
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Transcript of conference call on Financial Results for Q3 & 9M FY 24

Dr. Lal Pathlabs Ltd. Technical Scans

Thu, 29 Feb 2024
Making Lower Lows for 3 days Making Lower Lows for 3 days
Close Below Last Week Low Close Below Last Week Low
Close Below Last Month Low Close Below Last Month Low
Making Lower Lows for 2 Days Making Lower Lows for 2 Days
High Decrease in 3 Months High Decrease in 3 Months

Dr. Lal Pathlabs Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 378,183.18 1,577.95 +0.3%
Cipla Ltd. 119,792.84 1,480.35 +0.2%
Dr. Reddy's Laboratories Ltd. 107,100.71 6,424.25 -0.1%
Zydus Lifesciences Ltd. 95,405.30 941.90 +1.0%
Divi's Laboratories Ltd. 92,624.64 3,489.10 -0.7%
Torrent Pharmaceuticals Ltd. 90,256.63 2,666.80 +2.2%
Apollo Hospitals Enterprise Ltd. 87,793.47 6,105.90 -3.9%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 42.46 1,577.95 +0.3%
Cipla Ltd. Consolidated 2023-12 32.31 1,480.35 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 20.49 6,424.25 -0.1%
Zydus Lifesciences Ltd. Consolidated 2023-12 32.08 941.90 +1.0%
Divi's Laboratories Ltd. Consolidated 2023-12 66.98 3,489.10 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 60.41 2,666.80 +2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 111.23 6,105.90 -3.9%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 6.06 1,577.95 +0.3%
Cipla Ltd. Consolidated 2023-12 4.63 1,480.35 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.99 6,424.25 -0.1%
Zydus Lifesciences Ltd. Consolidated 2023-12 4.91 941.90 +1.0%
Divi's Laboratories Ltd. Consolidated 2023-12 7.11 3,489.10 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 12.62 2,666.80 +2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 13.00 6,105.90 -3.9%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,577.95 +0.3%
Cipla Ltd. Consolidated 2023-03 0.02 1,480.35 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,424.25 -0.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 941.90 +1.0%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,489.10 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,666.80 +2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,105.90 -3.9%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,577.95 +0.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,480.35 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,424.25 -0.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 941.90 +1.0%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,489.10 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,666.80 +2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,105.90 -3.9%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,577.95 +0.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,480.35 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,424.25 -0.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 941.90 +1.0%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,489.10 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,666.80 +2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,105.90 -3.9%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,577.95 +0.3%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,480.35 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,424.25 -0.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 941.90 +1.0%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,489.10 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,666.80 +2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,105.90 -3.9%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,577.95 +0.3%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,480.35 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,424.25 -0.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 941.90 +1.0%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,489.10 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,666.80 +2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,105.90 -3.9%

Dr. Lal Pathlabs Ltd. FAQ's

What is Dr. Lal Pathlabs share price?

Can I buy Dr. Lal Pathlabs shares now?

What is the Dividend Yield of Dr. Lal Pathlabs?

What is the Market Cap of Dr. Lal Pathlabs?

What are the key metrics to analyse Dr. Lal Pathlabs?

What is the 52 Week High and Low of Dr. Lal Pathlabs?

What is the trend of Dr. Lal Pathlabs share price?